VITA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 24.462
AS - Asia 12.648
EU - Europa 9.560
SA - Sud America 2.339
Continente sconosciuto - Info sul continente non disponibili 842
AF - Africa 289
OC - Oceania 49
Totale 50.189
Nazione #
US - Stati Uniti d'America 23.949
SG - Singapore 4.530
CN - Cina 4.127
IT - Italia 2.609
UA - Ucraina 2.032
BR - Brasile 1.943
HK - Hong Kong 1.490
DE - Germania 1.101
FR - Francia 715
VN - Vietnam 618
GB - Regno Unito 588
FI - Finlandia 545
TR - Turchia 455
RU - Federazione Russa 450
BD - Bangladesh 425
PL - Polonia 395
IE - Irlanda 392
IN - India 330
CA - Canada 253
SE - Svezia 150
MX - Messico 147
AR - Argentina 138
CZ - Repubblica Ceca 109
NL - Olanda 109
ZA - Sudafrica 94
IQ - Iraq 93
JP - Giappone 91
ID - Indonesia 85
ES - Italia 70
EC - Ecuador 63
SA - Arabia Saudita 59
CO - Colombia 54
BE - Belgio 52
AT - Austria 49
AU - Australia 47
PK - Pakistan 46
UZ - Uzbekistan 44
NG - Nigeria 42
VE - Venezuela 42
PY - Paraguay 33
LT - Lituania 32
IR - Iran 31
MA - Marocco 30
EU - Europa 29
CH - Svizzera 28
EG - Egitto 25
CL - Cile 23
JM - Giamaica 23
KE - Kenya 23
PE - Perù 21
PH - Filippine 21
NP - Nepal 18
TN - Tunisia 18
CR - Costa Rica 17
ET - Etiopia 17
GR - Grecia 17
IL - Israele 17
JO - Giordania 17
AE - Emirati Arabi Uniti 15
AL - Albania 15
AZ - Azerbaigian 15
PT - Portogallo 15
DZ - Algeria 14
HN - Honduras 14
KR - Corea 14
MY - Malesia 14
HU - Ungheria 13
BG - Bulgaria 12
RO - Romania 12
UY - Uruguay 11
KG - Kirghizistan 10
KZ - Kazakistan 10
DO - Repubblica Dominicana 9
GT - Guatemala 9
OM - Oman 9
PS - Palestinian Territory 9
BO - Bolivia 8
PA - Panama 8
TT - Trinidad e Tobago 8
AM - Armenia 7
BY - Bielorussia 7
CI - Costa d'Avorio 7
LB - Libano 7
TH - Thailandia 7
BB - Barbados 6
DK - Danimarca 6
LV - Lettonia 6
NO - Norvegia 6
SN - Senegal 6
A1 - Anonimo 5
BH - Bahrain 5
MU - Mauritius 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
LK - Sri Lanka 4
RS - Serbia 4
SV - El Salvador 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
KW - Kuwait 3
Totale 49.326
Città #
Singapore 2.451
Fairfield 2.179
Ashburn 2.036
Woodbridge 1.782
Jacksonville 1.541
Hong Kong 1.477
Houston 1.333
Chandler 1.119
The Dalles 958
Seattle 871
San Jose 867
Cambridge 856
Ann Arbor 807
Wilmington 787
Beijing 774
Princeton 722
New York 655
Council Bluffs 555
Nanjing 517
Los Angeles 426
Lauterbourg 400
Dublin 389
Warsaw 383
Brescia 380
Istanbul 374
Helsinki 331
Milan 331
Dallas 279
Columbus 241
Munich 230
Ho Chi Minh City 218
Des Moines 189
Nanchang 185
Redondo Beach 174
Buffalo 172
São Paulo 171
Changsha 164
Moscow 164
Dearborn 154
Rome 143
Shenyang 138
Boardman 136
Chicago 134
Santa Clara 133
Tianjin 133
Lancaster 132
Jinan 127
Hebei 124
Hanoi 122
Shanghai 121
San Diego 114
San Francisco 105
Orem 98
London 89
Hangzhou 83
Toronto 82
Jiaxing 80
Frankfurt am Main 79
Brooklyn 77
Tokyo 77
Brno 71
Mexico City 66
Turku 63
Zhengzhou 62
Romola 60
Guangzhou 58
Montreal 58
Rio de Janeiro 56
Belo Horizonte 54
Kunming 54
Phoenix 54
Atlanta 53
Nuremberg 51
Washington 50
San Mateo 49
Johannesburg 48
Chennai 45
Denver 45
Tashkent 43
Stockholm 42
Turin 41
Abuja 40
Jakarta 40
Manchester 40
Augusta 37
Brussels 37
Naples 36
Salt Lake City 35
Amsterdam 34
Boston 34
Lanzhou 34
Norwalk 34
Verona 34
Mumbai 33
Ningbo 33
Charlotte 32
Haikou 31
Paris 31
Taizhou 31
Brasília 30
Totale 31.748
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 480
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 324
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 274
Il training cognitivo nei pazienti affetti da schizofrenia 249
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 238
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 235
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 221
Autism spectrum disorder and schizophrenia: Do they overlap? 215
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 210
Cognitive remediation in schizophrenia: current status and future perspectives. 203
The patient journey project in Italian mental health services: results from a co-designed survey on clinical interventions and current barriers to improve the care of people living with schizophrenia 200
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 200
Correlates of autistic traits among patients with borderline personality disorder 199
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 198
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 192
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 190
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 189
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 186
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 185
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 185
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 185
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 183
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 182
Cognitive remediation in schizophrenia. 178
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 178
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 177
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 177
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 177
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 177
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 177
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 177
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 175
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 174
A roadmap to disentangle the molecular etiology of schizophrenia 172
Autistic symptoms predict social cognitive performance in patients with schizophrenia 172
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 170
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 168
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 165
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 165
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 165
Factors Associated With Brain Heterogeneity in Schizophrenia 163
Translation and Validation of Italian Version of Index of Dental Anxiety and Fear (IDAF-4C+): A Cross-Sectional Study 163
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 162
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 162
Adherence to antipsychotics in schizophrenia. 161
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 161
Antipsychotics, antidepressants, anticonvulsants, and placebo on symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials 160
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 160
Cognitive remediation in the early course of schizophrenia: a critical review. 160
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 160
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 159
Developmental brain abnormalities in schizophrenia: contributions of genetic and perinatal factors. 157
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 157
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 157
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 157
A genome-wide search for schizophrenia susceptibility genes. 156
Brain structural effects of antidepressant treatment in major depression 156
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 156
Prevalence and Characteristics of Chemsex: A Cross-Sectional Observational Study 155
Cognitive remediation in schizophrenia: a controlled study 155
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 154
Neuropsychological features in patients with severe mental disorders and risk of violence: A prospective multicenter study in Italy 153
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 151
Tools for measuring clinical effectiveness. 151
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials 150
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices 149
Additional Support for Schizophrenia Linkage on Chromosomes 6 and 8: A Multicenter Study 149
Age of onset in familial schizophrenia. 148
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 148
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 147
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 146
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 146
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 146
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 146
Season of birth and cerebral ventricular enlargement in schizophrenia 146
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 146
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 146
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 146
HLA-DR antigens in schizophrenia. 145
Catatonia Spectrum: Validation of a Questionnaire Investigating Catatonia Spectrum 143
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 143
Post-traumatic stress disorder and subthreshold post-traumatic stress disorder in recent male asylum seekers: An expected but overlooked “European” epidemic 143
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 142
Fertility and marital status in mood disorders: relationship with age at onset. 142
New Strategies to Improve Cognitive Symptom Domain in the Treatment of Schizophrenia 141
Cortical atrophy in schizophrenia: prevalence and associated features 141
Uso della PET e della SPECT in psichiatria 141
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 141
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 141
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 140
CT scan abnormalities and outcome of chronic schizophrenia 140
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 140
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 140
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review 139
Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. 139
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 139
Carlo Lorenzo Cazzullo (1915-2010): father of Italian psychiatry 139
Editorial: Insights in social psychiatry and psychiatric rehabilitation: 2022: Foreword 138
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 138
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services 138
Totale 17.005
Categoria #
all - tutte 249.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 249.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.389 0 463 58 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20243.083 207 90 249 209 167 558 109 84 634 81 58 637
2024/20257.512 93 98 144 820 866 631 594 238 893 711 1.569 855
2025/202615.108 1.445 1.983 1.197 1.999 1.371 1.070 2.143 602 844 1.334 710 410
2026/20271.363 761 602 0 0 0 0 0 0 0 0 0 0
Totale 50.189